in patients with pulmonary diseases , serum alpha 1-antitrypsin ( aat ) was measured by three methods : radial immunodiffusion ( rid ) , trypsin inhibitory capacity assay ( tic ) and by rate nephelometry with the immunosystem ( nia ) in a total of 369 subjects ( sarcoidosis , n = 35 ; asthma , n = 41 ; chronic obstructive bronchitis , n = 62 ; bronchogenic carcinoma , n = 93 ; pneumonia , n = 24 ; tuberculosis , n = 43 ; fibrosis , n = 22 ; healthy controls , n = 49 ) .
C0024115
pulmonary diseases
C0032285
pneumonia